Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could ...

Andy Feds, a comedian born with HIV, married his wife Jasmine Collins-Badeau, who is not living with HIV, and they are looking forward to welcoming a child into their family with an HIV-negative ...

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering the sugars on their surface, hindering the host immune system and avoiding ...

Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. Researchers ...

Introduction Towards the ‘End TB Strategy’ targets, the WHO recommends the provision of tuberculosis (TB) preventive therapy ...

The immune system remains seriously out-of-whack – in an inflammatory state of overactivation and impaired functionality – ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

TB remains the leading cause of death among people living with HIV. Uganda is a high TB-burden country, and HIV accelerates ...

Florida's recent decision to narrow eligibility for the Ryan White AIDS Drug Assistance Program (ADAP) is expected to limit ...